Huakang Biomedical Holdings Company Limited reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was CNY 6.4 million compared to CNY 6.89 million a year ago. Net loss was CNY 0.295 million compared to CNY 0.57 million a year ago. Basic loss per share from continuing operations was CNY 0.0007 compared to CNY 0.0014 a year ago. For the nine months, sales was CNY 18.57 million compared to CNY 14.1 million a year ago. Net loss was CNY 2.34 million compared to CNY 6.68 million a year ago.